Evidence map›Paper›PMID 38282049›Full record

ArticleMolecular biology reports2024

Identification of novel and de novo variant in the SCN1A gene confirms Dravet syndrome in Moroccan child: a case report.

Hinde El Mouhi, Nada Amllal, Meriame Abbassi, Ayoub Nedbour, Meryem Jalte, Jaber Lyahyai, Siham Chafai Elalaoui, Laila Bouguenouch, Sana Chaouki

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. World journal of experimental medicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Hinde El MouhiLaboratory of Biomedical and Translational Research, Faculty of Medicine and Pharmacy and Dental Medicine, Sidi Mohammed Ben Abdellah University, Fez, Morocco. hinde.elmouhi@usmba.ac.ma.ORCID http://orcid.org/0000-0003-4787-3100
Nada AmllalResearch Team in Genomics and Molecular Epidemiology of Genetic Diseases, Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco.
Meriame AbbassiLaboratory of Biomedical and Translational Research, Faculty of Medicine and Pharmacy and Dental Medicine, Sidi Mohammed Ben Abdellah University, Fez, Morocco.
Ayoub NedbourUnit of Medical Genetics and Oncogenetics, University Hospital Hassan II, Fez, Morocco.
Meryem JalteUnit of Medical Genetics and Oncogenetics, University Hospital Hassan II, Fez, Morocco.
Jaber LyahyaiResearch Team in Genomics and Molecular Epidemiology of Genetic Diseases, Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco.
Siham Chafai ElalaouiMedical Genetics Unit, CHU Ibn Sina, Rabat, Morocco.
Laila BouguenouchLaboratory of Biomedical and Translational Research, Faculty of Medicine and Pharmacy and Dental Medicine, Sidi Mohammed Ben Abdellah University, Fez, Morocco.
Sana ChaoukiLaboratory of Biomedical and Translational Research, Faculty of Medicine and Pharmacy and Dental Medicine, Sidi Mohammed Ben Abdellah University, Fez, Morocco.
Centre Hospitalier Universitaire Hassan II · MAMohammed V University · MACentre Hospitalier Ibn Sina · MAInstituts Supérieurs des Professions Infirmières et Techniques de Santé · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dravet syndrome is a severe form of epilepsy characterised by recurrent seizures and cognitive impairment. It is mainly caused by variant in the SCN1A gene in 90% of cases, which codes for the α subunit of the voltage-gated sodium channel. In this study, we present one suspected case of Dravet syndrome in Moroccan child that underwent exome analysis and were confirmed by Sanger sequencing. The variant was identified in the SCN1A gene, and is a new variant that has never been described in the literature. The variant was found de nova in our case, indicating that it was not inherited from the parents. The variant, SCN1A c.965-2A>G p.(?), is located at the splice site and results in an unknown modification of the protein. This variant is considered pathogenic on the basis of previous studies. These results contribute to our knowledge of the SCN1A gene mutations associated with Dravet syndrome and underline the importance of genetic analysis in the diagnosis and confirmation of this disorder. Further studies are needed to better understand the functional consequences of this variant and its implications for therapeutic strategies in Dravet syndrome.

Indexed as

Epilepsies, MyoclonicEpilepsyChildHumansMutationNAV1.1 Voltage-Gated Sodium ChannelSeizuresSequence AnalysisNAV1.1 Voltage-Gated Sodium ChannelSCN1A protein, humanDe nova variantDravet syndromeExome analysisNovel variantSanger sequencingSCN1A gene

Identifiers

PMID38282049
OpenAlexW4391291201

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.